Total raised
$8.0M
Last: Seed 2024-08
Stage
Seed
Founded
2024
Headcount
18
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Cassidy Bio is an AI-first biotechnology company building the first programmable platform for gene editing. Cassidy Bio replaces the narrow, trial-and-error design process with large-scale prediction, simulation, and in silico validation, powered by genomic foundation models trained on proprietary biological data. The platform scales to connect across multiple components guides, editing systems, delivery systems and variant backgrounds ranking designs by safety and efficacy. Cassidy Bio’s vision is to enable not just one-off miracles, but a new generation of reliable gene editing therapies at scale.
Funding history · 1 round · $8.0M total
2024-08
Seed
$8.0M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Cassidy Bio founded?
- Cassidy Bio was founded in March 2024.
- What is Cassidy Bio's primary focus?
- Cassidy Bio is an AI-first biotechnology company focused on building a programmable platform for gene editing, aiming to improve safety and specificity in therapy development.
- How much funding has Cassidy Bio raised to date?
- Cassidy Bio has raised a total of $8,000,000 USD.
- When did Cassidy Bio complete its Seed funding round?
- Cassidy Bio completed its Seed funding round in August 2024, raising $8,000,000 USD.
- Which investors participated in Cassidy Bio's Seed round?
- Cassidy Bio's Seed round included investments from AION Labs, 10D, UnBox Ventures, Ahren Innovation Capital, and lool ventures.
- Where is Cassidy Bio headquartered?
- Cassidy Bio is headquartered in Tel Aviv-Yafo, Israel.
- How many employees does Cassidy Bio currently have?
- Cassidy Bio currently has 18 employees.
- Who are the founders of Cassidy Bio?
- The founders of Cassidy Bio are Rom Kshuk, Ayal Hendel, and Yaniv Shmueli.
- What technologies does Cassidy Bio utilize in its platform?
- Cassidy Bio utilizes Artificial Intelligence, Machine Learning, Biologicals, and Genes in its platform for gene editing.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B
Tags
pharmaceuticalsgenome-editingtherapeuticsbiotechnology